Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells

Human Gene Therapy
L YangD Parekh

Abstract

A bystander effect is described when nontransduced or genetically unmodified cells are killed during death of genetically modified tumor cells transduced with a suicide gene. The "bystander effect" greatly enhances the efficacy of the herpes simplex virus-thymidine kinase/ganciclovir (HSV-TK/GCV) gene therapy approach for cancer. The mechanism of the bystander effect is controversial. In this study, we examined the role of intercellular gap junction communication (GJIC) for the bystander effect in human gastrointestinal tumor cells. Our results show that the extent of the bystander effect varied amongst the tumor cell lines; pancreatic cancer cells BXPC-3 exhibited excellent bystander effects in vitro and in vivo studies whereas other gastrointestinal tumor cell lines such as pancreatic cancer cells MIAPACA-2, and colon cancer cells HT-29 showed poor bystander effects. Bystander effects were only found in the presence of cell-to-cell contact. The extent of the bystander effect was independent of the level of HSV-TK activity in the transduced tumor cells and was correlated with GJIC as demonstrated by an in vitro dye-transfer assay. Expression of the mRNA levels of gap junction protein connexin 43 was 8- to 26-fold or greater an...Continue Reading

References

Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·J FickM A Israel
Nov 1, 1994·Molecular Carcinogenesis·J D Pitts
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·D BarbaF H Gage
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Jan 19, 1994·Journal of the National Cancer Institute·L Seachrist
Nov 1, 1993·Journal of Neurosurgery·D BarbaF H Gage
Apr 1, 1993·Cancer·K Seiter, N Kemeny
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·M MesnilH Yamasaki
Jan 1, 1997·Journal of the National Cancer Institute·J A Roth, R J Cristiano

❮ Previous
Next ❯

Citations

Feb 20, 2004·Current Surgery·Pedro J Ramírez, Selwyn M Vickers
Oct 8, 1999·Pharmacology & Therapeutics·G M Dubowchik, M A Walker
Feb 13, 2001·Journal of Virological Methods·N O FischerR I Woodruff
Jul 21, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·K S FrederiksenH S Poulsen
Nov 13, 2001·International Journal of Radiation Oncology, Biology, Physics·M T VlachakiE Aguilar-Cordova
Feb 1, 2000·Molecular Medicine Today·G A Chung-FayeP F Searle
Mar 17, 2010·Chemical Reviews·Angelique Louie
May 12, 2000·The Laryngoscope·L L Gleich
Jul 5, 2005·Expert Opinion on Investigational Drugs·M J PerryA G Dalgleish
Aug 19, 1999·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·R HustinxA Alavi
Jun 16, 2005·Biochimica Et Biophysica Acta·Jean X Jiang, Sumin Gu
Apr 23, 2014·International Journal of Cancer. Journal International Du Cancer·Solveig SirnesEdward Leithe
Sep 24, 2016·Nature Reviews. Cancer·M Teresa Villanueva
Nov 4, 2016·Nature Reviews. Cancer·Trond AasenDale W Laird
Apr 27, 2004·Cancer Gene Therapy·Liliana M E FinocchiaroGerardo C Glikin
Jul 10, 2001·International Journal of Urology : Official Journal of the Japanese Urological Association·I YoshimuraM Hayakawa
Jul 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Makoto AsamotoTomoyuki Shirai
May 29, 2002·Cancer Gene Therapy·Jörg KleeffMurray Korc
Oct 14, 2014·World Journal of Gastroenterology : WJG·Si-Xue LiuYing-Qiang Zhong
Oct 13, 2006·World Journal of Gastroenterology : WJG·Ruben Hernandez-AlcocebaJesus Prieto
Jan 18, 2003·World Journal of Gastroenterology : WJG·Shan-Yu GuoYan-Zhen Lin
Aug 22, 2017·Frontiers in Molecular Neuroscience·Dominique ThuringerCarmen Garrido

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.